FDA approves Farxiga for heart failure with reduced ejection fraction
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
May 7, 2020
0
1